Psoriasis is a common skin disease that affects the life
cycle of skin cells. Psoriasis causes cells to build up on the surface of the
skin, resulting in itchy, red patches that are sometimes painful. Cases of psoriasis
can range from mild to severe and can affect different areas of the body,
including the scalp, nails, underarms and groin.
According to the article, patients with mild psoriasis have
an increased risk for Type 2 diabetes of 49% over the general population. In
addition, those patients diagnosed with severe psoriasis are more than twice as
likely to also be diagnosed with diabetes. These are startling findings,
especially considering that there are approximately 125 million reported cases
of psoriasis worldwide.
“Diabetes and psoriasis share an underlying inflammatory
process and an abundance of risk factors, and therefore, it is not surprising
that psoriasis has been proposed as a risk factor for new onset diabetes,” said
Dr. Ahlehoff, who announced the results of this study at the European Society
of Cardiology meeting; the study’s results are detailed here.
“Screening for diabetes and cardiovascular risk factors in
patients with psoriasis is warranted,” Dr. Ahlehoff concludes. He suggests that
a yearly screening should be sufficient.
While the cause of psoriasis is not fully known, researchers
suspect that it is related to the immune system and how it reacts to the
environment. Some triggers have been identified and should be avoided if
possible. These include: infections such as strep throat, injuries to the skin
including cuts, scrapes and bug bites, stress, cold weather and heavy alcohol
consumption.
In some cases, psoriasis may be more of a nuisance than a
major health concern; however, this is a disease that can often lead to joint
problems and now, possibly Type 2 diabetes. Even in the mildest cases of
psoriasis, it is important to consult with a medical professional. If you think
you may have psoriasis or would like more information, I encourage you to call
us at 864-242-5872 to schedule your appointment.
No comments:
Post a Comment